Intel Capital, Mastercard, American Express and Santander will all exit in the deal, which more than doubled iZettle's valuation in five months.

Acousia has raised $11.8m from backers including Boehringer Ingelheim Venture Fund to advance therapies for inner-ear impairments into the clinic.

Polyphor, which has collaboration agreements in place with multiple pharmaceutical companies, raised $155m when it floated on the SIX Swiss Exchange.

University of Birmingham has spun out Viatem to develop a treatment for rheumatoid arthritis.

The Cambridge spinout has raised $15m in series A funding from investors including Cambridge Enterprise and Parkwalk Advisors.

Oriola took a 17% stake in the corporate health services startup through through the round, having already been a strategic partner.

BBVA's Propel Venture Partners fund co-led an $18.5m round for the mortgage comparison platform with Goldman Sachs Principal Strategic Investments.

Loughborough spinout Micropore Technologies has moved its emulsion systems business to Teeside, where it has gained support from economic redevelopment unit UK Steel Enterprise.